Expressing the human SCD5 in the livers of Scd1 GKO mice reversed several metabolic effects of Scd1 ablation, such as protection against obesity, hyperglycemia, and hepatic steatosis (24). This evidence concerns the gene SCD5 and Hepatic steatosis.